SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : 2021 Biotech Stock Picking Charity Contest

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: technetium who wrote (194)8/14/2021 4:27:56 PM
From: ErikOtto1 Recommendation

Recommended By
BulbaMan

   of 307
 
It's really been a brutal year, especially in small and mid cap biotech, and the indices aren't reflective of it at all. It seems like FDA is showing a great deal more scrutiny, and there are many pricing paradigms being floated in government that could negatively impact the sector. Add to that a slew of bad data releases and trial holds and here we are. I am really hoping things improve in the second half.

Honestly it wouldn't be that bad if I thought these pricing plans proposed in government made any sense. The problem is with the insurance system, PBMs and rebates - until they address that fundamental issue nothing matters - it will only stifle innovation but not really reduce prices for patients. Then you have situations like the BIIB approval and ridiculous list price overreach that is just sickening and only brings more concern about the sector. It feels like the system is breaking down and regulators / government are grasping at straws trying to fix it.

Anyway, I am saying all this not just to be a negative nellie, but to say thanks to technetium for continuing to tabulate the stats here, especially with the terrible sector sentiment. I for one appreciate it and welcome any associated commentary.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext